Reference health
Quality by Design Approach in Liposomal Formulations: Robust Product Development
145/145 checkable references clean · checked 2026-07-24
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
11 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 145 checked references that resolve
resolves10.2174/157341311795542453
Liposomes: A Review of Manufacturing Techniques and Targeting Strategies
resolves10.1016/j.ejphar.2021.173930
COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes
resolves10.31925/farmacia.2018.5.9
APPLICATION OF THE QUALITY BY DESIGN CONCEPT IN THE DEVELOPMENT OF QUERCETIN-LOADED POLYMERIC NANOPARTICLES
resolves10.1002/jps.21923
Quality‐by‐Design (QbD): An Integrated Process Analytical Technology (PAT) Approach for Real‐Time Monitoring and Mapping the State of a Pharmaceutical Coprecipitation Process
resolves10.1007/s11095-007-9511-1
Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control
resolves10.1016/j.ijpharm.2017.04.078
Nanostructured lipid carriers employing polyphenols as promising anticancer agents: Quality by design (QbD) approach
resolves10.1016/j.comtox.2018.04.001
Butylated hydroxytoluene, a food additive, modulates membrane potential and increases the susceptibility of rat thymocytes to oxidative stress
resolves10.1016/j.tibtech.2009.06.006
Roadmap for implementation of quality by design (QbD) for biotechnology products
resolves10.1016/j.ijpharm.2013.08.074
Latent variable modeling to assist the implementation of Quality-by-Design paradigms in pharmaceutical development and manufacturing: A review
resolves10.1016/j.ijpharm.2015.03.005
Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films
resolves10.3109/10837450.2011.627869
Real-time assessment of critical quality attributes of a continuous granulation process
resolves10.1016/j.drudis.2018.12.002
Quality-by-design approach as a systematic tool for the development of nanopharmaceutical products
resolves10.1016/j.ijpharm.2018.06.052
A practical framework for implementing Quality by Design to the development of topical drug products: Nanosystem-based dosage forms
resolves10.1016/j.talanta.2010.11.051
Optimization of a pharmaceutical freeze-dried product and its process using an experimental design approach and innovative process analyzers
resolves10.1007/s13346-019-00641-2
Development of anti-angiogenic erlotinib liposomal formulation for pulmonary hypertension: a QbD approach
resolves10.1016/j.ijpharm.2020.119696
Cefoperazone sodium liposomal formulation to mitigate P. aeruginosa biofilm in Cystic fibrosis infection: A QbD approach
resolves10.1016/j.ijpharm.2019.03.021
Application of the QbD-based approach in the early development of liposomes for nasal administration
resolves10.1016/j.jsps.2017.01.007
A quality by design approach for the development of lyophilized liposomes with simvastatin
resolves10.1080/08982104.2016.1254242
Optimization of prednisolone-loaded long-circulating liposomes via application of Quality by Design (QbD) approach
resolves10.1080/03639045.2017.1395457
A step forward towards the development of stable freeze-dried liposomes: a quality by design approach (QbD)
resolves10.3390/polym13020250
QbD Enabled Azacitidine Loaded Liposomal Nanoformulation and Its In Vitro Evaluation
resolves10.1016/j.jddst.2019.101336
Lectin coupled liposomes for pulmonary delivery of salbutamol sulphate for better management of asthma: Formulation development using QbD approach
resolves10.2147/DDDT.S129008
Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach
resolves10.1007/s13346-015-0220-8
Influence of cholesterol on liposome stability and on in vitro drug release
resolves10.1016/j.ijpharm.2012.06.002
Application of quality by design to formulation and processing of protein liposomes
resolves10.1021/acs.jpcb.5b02891
Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems
resolves10.1038/274921a0
Evidence for translation of rabbit globin mRNA after liposomemediated insertion into a human cell line
resolves10.1023/A:1018932714745
Comparison of Cell Proliferation and Toxicity Assays Using Two Cationic Liposomes
resolves10.1021/bi9801154
A Novel Tetraester Construct That Reduces Cationic Lipid-Associated Cytotoxicity. Implications for the Onset of Cytotoxicity
resolves10.1016/j.jcis.2011.05.023
Synthesis, characterization and comparative evaluation of phenoxy ring containing long chain gemini imidazolium and pyridinium amphiphiles
resolves10.1021/jm0499763
Pyridinium Cationic Lipids in Gene Delivery: A Structure−Activity Correlation Study
resolves10.1039/C7RA00422B
Cationic lipids with a cyclen headgroup: synthesis and structure–activity relationship studies as non-viral gene vectors
resolves10.1016/j.heliyon.2022.e09394
Liposomes: structure, composition, types, and clinical applications
resolves10.2147/IJN.S203330
<p>Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells</p>
resolves10.3109/08982104.2013.826243
Applying quality by design (QbD) concept for fabrication of chitosan coated nanoliposomes
resolves10.1016/j.ejpb.2007.08.001
Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
resolves10.1016/j.ijpharm.2011.11.036
A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale
resolves10.1038/nbt.3330
Principles of nanoparticle design for overcoming biological barriers to drug delivery
resolves10.1007/s00403-011-1166-4
Liposomal systems as drug delivery vehicles for dermal and transdermal applications
resolves10.15171/apb.2016.021
The Impact of Variables on Particle Size of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers; A Comparative Literature Review
resolves10.1016/j.addr.2015.09.012
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
resolves10.3390/pharmaceutics11110619
Electrostatically Driven Encapsulation of Hydrophilic, Non-Conformational Peptide Epitopes into Liposomes
resolves10.3390/pharmaceutics8030025
Influence of the Encapsulation Efficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes
resolves10.1016/j.ijpharm.2011.07.012
A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment
resolves10.1080/08982100802129372
Influence of Drug-to-Lipid Ratio on Drug Release Properties and Liposome Integrity in Liposomal Doxorubicin Formulations
resolves10.1021/acsomega.9b00825
Liposomal Nanovesicles for Efficient Encapsulation of Staphylococcal Antibiotics
resolves10.3109/08982104.2014.987787
Optimizing long-circulating liposomes for delivery of simvastatin to C26 colon carcinoma cells
resolves10.3390/biom9100513
Regulation of Membrane Calcium Transport Proteins by the Surrounding Lipid Environment
resolves10.1016/j.bbamem.2006.01.023
Preparation of submicron unilamellar liposomes by freeze-drying double emulsions
resolves10.1039/C9RA07560G
Remote loading of curcumin-in-modified β-cyclodextrins into liposomes using a transmembrane pH gradient
resolves10.1080/10717544.2016.1177136
Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape
resolves10.1016/j.addr.2012.09.037
Liposomal drug delivery systems: From concept to clinical applications
resolves10.1039/D0RA07325C
Grafting of anti-nucleolin aptamer into preformed and remotely loaded liposomes through aptamer-cholesterol post-insertion
resolves10.3390/molecules25010003
Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
resolves10.3389/fonc.2021.623760
Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment
resolves10.1016/j.ejpb.2018.11.001
Development of doxorubicin hydrochloride loaded pH-sensitive liposomes: Investigation on the impact of chemical nature of lipids and liposome composition on pH-sensitivity
resolves10.1016/j.ejpb.2015.01.030
Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery
resolves10.1016/j.jconrel.2017.04.019
Nanosystem trends in drug delivery using quality-by-design concept
resolves10.3390/pharmaceutics12121164
A Proposed Methodology for a Risk Assessment-Based Liposome Development Process
resolves10.3390/pharmaceutics10030139
Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging
resolves10.1021/acs.analchem.5b03798
High Throughput Identification and Quantification of Phospholipids in Complex Mixtures
resolves10.1016/0021-9673(91)85083-R
Determination of phosphatidylcholine, phosphatidylglycerol and their lyso forms from liposome dispersions by high-performance liquid chromatography using high-sensitivity refractive index detection
resolves10.1016/S0378-4347(00)00594-6
Simultaneous quantification of components of neoglycolipid-coated liposomes using high-performance liquid chromatography with evaporative light scattering detection
resolves10.1016/j.jpba.2020.113642
Analytical characterization of liposomes and other lipid nanoparticles for drug delivery
resolves10.1016/j.chroma.2004.12.036
A rapid isocratic high-performance liquid chromatography method for determination of cholesterol and 1,2-dioleoyl-sn-glycero-3-phosphocholine in liposome-based drug formulations
resolves10.1016/0003-2697(78)90412-8
A convenient and sensitive fluorescence assay for phospholipid vesicles using diphenylhexatriene
resolves10.1021/jf1038426
Lipid Fatty Acid Profile Analyses in Liver and Serum in Rats with Nonalcoholic Steatohepatitis Using Improved Gas Chromatography−Mass Spectrometry Methodology
resolves10.1021/acs.analchem.5b01054
High-Throughput and Comprehensive Lipidomic Analysis Using Ultrahigh-Performance Supercritical Fluid Chromatography–Mass Spectrometry
resolves10.1007/s00216-015-8805-0
Rapid evaluation of the quantity of drugs encapsulated within nanoparticles by high-performance liquid chromatography in a monolithic silica column
resolves10.1016/j.chroma.2016.12.080
High performance liquid chromatography analysis of 100-nm liposomal nanoparticles using polymer-coated, silica monolithic columns with aqueous mobile phase
resolves10.1016/j.jchromb.2011.10.004
Direct, simultaneous measurement of liposome-encapsulated and released drugs in plasma by on-line SPE–SPE–HPLC
resolves10.1016/j.chroma.2012.07.018
Physico-chemical characterization of liposomes and drug substance–liposome interactions in pharmaceutics using capillary electrophoresis and electrokinetic chromatography
resolves10.1016/j.jpba.2010.12.037
Characterization of a liposome-based formulation of oxaliplatin using capillary electrophoresis: Encapsulation and leakage
resolves10.1016/j.ijpharm.2013.03.055
Determination of platinum drug release and liposome stability in human plasma by CE-ICP-MS
resolves10.1038/s41556-018-0040-4
Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation
resolves10.1088/0026-1394/50/6/663
Particle size distributions by transmission electron microscopy: an interlaboratory comparison case study
resolves10.3390/polym9100521
(Cryo)Transmission Electron Microscopy of Phospholipid Model Membranes Interacting with Amphiphilic and Polyphilic Molecules
resolves10.3389/fphar.2018.00080
Advantages and Limitations of Current Imaging Techniques for Characterizing Liposome Morphology
resolves10.1016/0006-291X(87)91124-7
A 31P-NMR study on multilamellar liposomes formed from the lipids of a thermophilic bacterium
resolves10.1016/S0009-3084(00)00220-6
Parameters influencing the determination of liposome lamellarity by 31P-NMR
resolves10.1007/s12551-016-0218-6
Dynamic light scattering: a practical guide and applications in biomedical sciences
resolves10.1016/j.jconrel.2019.02.030
Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity
resolves10.1016/j.ejpb.2005.03.006
Characterisation of surface-modified solid lipid nanoparticles (SLN): Influence of lecithin and nonionic emulsifier
resolves10.21769/BioProtoc.2030
Ionization Properties of Phospholipids Determined by Zeta Potential Measurements
resolves10.1016/S0006-3495(92)81897-0
Sterically stabilized liposomes. Reduction in electrophoretic mobility but not electrostatic surface potential
resolves10.1098/rsta.2010.0175
High-concentration zeta potential measurements using light-scattering techniques
resolves10.1021/la0011634
Surface Potential of Charged Liposomes Determined by Second Harmonic Generation
resolves10.4103/0975-7406.76463
Differential scanning calorimetry: An invaluable tool for a detailed thermodynamic characterization of macromolecules and their interactions
resolves10.1080/08982100802310261
Differential Scanning Calorimetry (DSC): A Tool to Study the Thermal Behavior of Lipid Bilayers and Liposomal Stability
resolves10.1016/j.talanta.2012.01.018
An LC method for the analysis of phosphatidylcholine hydrolysis products and its application to the monitoring of the acyl migration process
resolves10.1007/s13346-013-0129-z
In vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challenges
resolves10.3390/pharmaceutics12080732
In Vitro Release Study of the Polymeric Drug Nanoparticles: Development and Validation of a Novel Method
resolves10.1208/s12248-017-0142-0
Role of In Vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective
resolves10.1016/j.ijpharm.2017.03.046
Analytical ultracentrifugation for analysis of doxorubicin loaded liposomes
resolves10.1007/s11095-005-9397-8
Methods to Assess in Vitro Drug Release from Injectable Polymeric Particulate Systems
resolves10.1016/j.jconrel.2019.09.016
Predicting drug release kinetics from nanocarriers inside dialysis bags
resolves10.1016/j.bbalip.2011.06.016
Lipid profiling of lipoproteins by electrospray ionization tandem mass spectrometry
resolves10.1016/0005-2736(77)90078-5
On the quantitative interpretation of biomembrane structure by Raman spectroscopy
resolves10.1016/j.ijpharm.2015.11.014
HPLC analysis as a tool for assessing targeted liposome composition
resolves10.1007/s11745-009-3382-7
An Improved Method for Determining Medium‐ and Long‐Chain FAMEs Using Gas Chromatography
resolves10.1093/clinchem/18.7.673
Improved Determination of Total Serum Lipids by the Sulfo-Phospho-Vanillin Reaction
resolves10.1080/20013078.2019.1565263
An improved 96 well plate format lipid quantification assay for standardisation of experiments with extracellular vesicles
resolves10.2147/IJN.S56582
Cryogenic transmission electron microscopy of recombinant tuberculosis vaccine antigen with anionic liposomes reveals formation of flattened liposomes
resolves10.1038/s41598-020-62500-2
Preparation of nanoliposomes by microfluidic mixing in herring-bone channel and the role of membrane fluidity in liposomes formation
resolves10.1016/j.jconrel.2020.01.049
Physical characterization of liposomal drug formulations using multi-detector asymmetrical-flow field flow fractionation
resolves10.3389/fchem.2022.963004
Liposomes as Multifunctional Nano-Carriers for Medicinal Natural Products
resolves10.3390/pharmaceutics14112463
Precision Nanotoxicology in Drug Development: Current Trends and Challenges in Safety and Toxicity Implications of Customized Multifunctional Nanocarriers for Drug-Delivery Applications
resolves10.3390/nano10020190
Immunological and Toxicological Considerations for the Design of Liposomes
resolves10.1016/j.toxlet.2009.01.008
DNA damaging potential of zinc oxide nanoparticles in human epidermal cells
resolves10.1038/nmeth1015
Three-dimensional culture models of normal and malignant breast epithelial cells
resolves10.1523/JNEUROSCI.18-18-07296.1998
Regional Selective Neuronal Degeneration after Protein Phosphatase Inhibition in Hippocampal Slice Cultures: Evidence for a MAP Kinase-Dependent Mechanism
The 11 references without a DOI — listed, not checked
no DOI — not checkedEuropean Medicines Agency, and Committee for Human Medicinal Products (2008). ICH Guideline Q10 on Pharmaceutical Quality System, European Medicines Agency.
no DOI — not checkedEuropean Medicines Agency (2006). ICH Guideline Q9 on Quality Risk Management, European Medicines Agency.
no DOI — not checkedA review on quality by design approach (QBD) for pharmaceuticals
no DOI — not checkedQbD based development of proliposome of lopinavir for improved oral bioavailability
no DOI — not checkedBarhoum, A., Jeevanandam, J., and Danquah, M.K. (2022). Chapter 12—Liposomal bionanomaterials for nucleic acid delivery. Fundamentals of Bionanomaterials, Elsevier.
no DOI — not checkedStealth liposomes and tumor targeting: One step further in the quest for the magic bullet
no DOI — not checkedLiposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications
no DOI — not checkedQuality by design case study 1: Design of 5-fluorouracil loaded lipid nanoparticles by the W/O/W double emulsion—Solvent evaporation method
no DOI — not checkedPreparation and characterization of stable nanoliposomal formulation of fluoxetine as a potential adjuvant therapy for drug-resistant tumors
no DOI — not checkedCell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
no DOI — not checkedLipid-Based Drug Delivery Systems
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-24 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.3390/molecules28010010"><img src="https://citestamp.com/citestamped/10.3390/molecules28010010/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.3390/molecules28010010)